Navigation Links
Substantial costs and underreporting of dengue fever, concerns about blood supply face US
Date:10/16/2007

Dengue fever, known as breakbone fever because of the excruciating back and joint pain that accompanies this infectious disease, is a growing public health threat for people living in tropical countries, as well as travelers to destinations such as Thailand, Brazil and Puerto Rico, according to research being presented at the annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH), Nov. 4-7.

Protocol Needed to Screen Blood Donors

Dengue, which is believed to infect millions of people annually in developing countries, and also causes some infections in Texas along the border of Mexico, is usually transmitted by mosquitoes. A recent study examined the prevalence of dengue virus among blood donors in Puerto Rico and found that one in every 1,300 donors tested positive during the 2005 epidemic, which means that this sometimes fatal disease might be transferred to others through the blood supply.

The frequency of finding dengue virus in blood donors during outbreaks is comparable to what we see with West Nile virus, said Susan Stramer, executive scientific officer, American Red Cross. However, we still need to better understand transfusion-associated transmission of dengue and the dynamics of the virus in donors. Still, the American Red Cross and public health officials plan to start dengue blood donor screening using a research protocol in Puerto Rico in 2008.

Underreporting Remains Public Health Concern

Researchers believe that dengue is grossly underreported in many countries. For example, in 2004, 557,000 cases and 1,800 deaths were reported globally to WHO, but the projected dengue burden was more than 8 million cases and nearly 20,000 deaths. In addition to underreporting, the lack of a rapid and accurate diagnostic test, potential misdiagnoses of milder forms of dengue as influenza, as well as limited data further challenge efforts to measure the global burden of this threatening disease. And, with no drugs available to treat dengue, patients prognosis relies on good medical management, including rest, fluids and pain relief.

Direct and Indirect Costs of Dengue

In the first comprehensive, multi-country analysis of dengue by all stakeholders (households, employers and public health systems), the new study reveals a substantial epidemiological, social and economic burden associated with the disease. On average, a hospitalized case of dengue costs three times that of an ambulatory case, said Jose Suaya, scientist at Brandeis University and co-investigator of the study, which was conducted in eight countries across South East Asia and South America from 2005-2006.

An episode of dengue has a tremendous impact on the government, households and employers, said Donald Shepard, professor at Brandeis University and co-investigator of the study. More attention is needed to understand global patterns of dengue and related costs to develop sound policy and appropriately allocate resources for its prevention and treatment. We believe this data is an important first step.

Researchers assessed direct medical costs, non-medical costs and indirect costs (e.g., days lost by patients and caretakers from school, work) and found that even though countries have major public health systems that pay for care, there was a heavy toll on households due to out-of-pocket expenses. For ambulatory patients, families assume most of the burden, and even when someone is hospitalized, they assume about 25% of the related costs.


'/>"/>

Contact: Amanda Crowe
acrowe@environics-usa.com
203-202-9454
American Society of Tropical Medicine and Hygiene
Source:Eurekalert

Related medicine news :

1. Hearing Loss in Children Leads to Substantial Meningitis Risk
2. Work Absence Due to Headaches Has a Substantial Socio-economic Effect
3. Genetic Variation is Linked to Substantial Risk in Heart Attack
4. India Records Substantial Decline in Polio Cases
5. Generic drug costs remain shackled
6. Obesity increases health costs
7. High development costs hinder entry of cancer super drugs into the market
8. Obese Employees Increase Costs For Employers
9. Hospital Cuts Costs By Moving Cancer Patients To Hotels
10. New screening test for MRSA could reduce infections and costs
11. Rising Medicare costs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Cambridge, MA (PRWEB) , ... December 08, 2016 , ... ... decreases in medical payments per workers’ compensation claim in 2013 and 2014, according to ... Workers Compensation Research Institute (WCRI) . , According to the study, medical payments per ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Dianne Michael Insurance Agency, ... Hamilton County, is embarking on a charity drive with the aim of generating ... for orphaned or neglected senior dogs in the Cincinnati region, and LuvFurMutts volunteers ...
(Date:12/8/2016)... ... December 08, 2016 , ... Coffey Agencies, a locally owned ... clients in the northern Alabama and Georgia regions, is embarking on a charity ... Works has built a network of support and education facilities to develop and ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... Kenall Manufacturing, ... new MedMaster™ MPCNGX . The MPCNGX is a multi-function, sealed, LED luminaire that ... amount of light where and when it’s needed. , A 2’ x ...
(Date:12/7/2016)... Atlanta, Georgia (PRWEB) , ... ... ... announced today it has acquired Presence Technology, S.L. (“Presence”) for a purchase ... certain price adjustments and other considerations. Presence’s annual revenue is approximately $13.2 ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Pennsylvania Physician General ... Drug and Alcohol Programs Gary Tennis ... medications, known as benzodiazepines, developed with the help ... are medications that are frequently prescribed for anxiety ... are used with opioid pain medications, benzodiazepines pose ...
(Date:12/8/2016)... -- A new study by a pair of Geisinger Health ... to treat chronic pain is not only ineffective, it ... including death. Palliative care physicians Mellar ... M.D., authored the study which provides a review of ... was published in the December 2016 edition of Current ...
(Date:12/8/2016)... 2016  EIP Pharma, LLC ( www.eippharma.com ) ... neflamapimod (previously code named VX-745), with the results ... that demonstrated significant Alzheimer,s disease relevant pharmacological activity.  ... Study 303 (6-week treatment) are the subject of ... (CTAD) scientific conference in San Diego, ...
Breaking Medicine Technology: